Nuclear Imaging System - ANVISA Registration 80071260408
Access comprehensive regulatory information for Nuclear Imaging System in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80071260408 and manufactured by GE MEDICAL SYSTEMS ISRAEL, FUNCTIONAL IMAGING. The registration is held by GE HEALTHCARE DO BRASIL COMERCIO E SERVICOS PARA EQUIPAMENTOS MEDICO-HOSPITALARES LTDA with validity until Dec 23, 2029.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including GE MEDICAL SYSTEMS ISRAEL, FUNCTIONAL IMAGING, GE HUALUN MEDICAL SYSTEMS CO. LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
80071260408
25351693753201914
00029372000140
Company Information
Dates and Status
Dec 23, 2019
23/12/2029
09/18/2025 19:00:01
GE MEDICAL SYSTEMS ISRAEL, FUNCTIONAL IMAGINGโข Israel
GE HUALUN MEDICAL SYSTEMS CO. LTDโข China
SIEMENS MEDICAL SOLUTIONS USA INCโข United States of America
SPECTRUM DYNAMICS (ISRAEL) LTDโข Israel
SIEMENS MEDICAL SOLUTIONS USA, INCโข United States of America
Sistema Nuclear de Formacao de Imagens
Sistema Nuclear de Formaรงรฃo de Imagens NM/CT
Not specified
80071260449
May 19, 2025
Sistema Nuclear de Formacao de Imagens
Sistema Nuclear de Formaรงรฃo de Imagens NM/CT
GE MEDICAL SYSTEMS ISRAEL, FUNCTIONAL IMAGING
80071260449
May 19, 2025
Sistema Nuclear de Formacao de Imagens
Sistema de Imagem Veriton CT
Not specified
80012590230
Jul 08, 2024
Sistema Nuclear de Formacao de Imagens
Sistema de Imagem Veriton CT
SPECTRUM DYNAMICS (ISRAEL) LTD
80012590230
Jul 08, 2024
Sistema Nuclear de Formacao de Imagens
Sistema SPECT/TC
Not specified
10345162478
Feb 26, 2024

